PUBLICATIONS

  1. Shrader, C.W.; Foster, D.; Kharel, Y.; Huang, T.; Lynch, K.R.; Santos, W.L. Imidazole-Based Sphingosine-1-phosphate Transporter Spns2 Inhibitors. Bioorg. Med. Chem. Lett.  2023, 96, 129516. [DOI]

  2. Burgio, A.; Shrader, C.W.; Kharel, Y.; Huang, T.; Salamoun, J.; Lynch, K.R.; Santos, W.L. 2-Aminobenzoxazole Derivatives as Potent Inhibitors of the Sphingosine-1-phosphate Transporter Spinster Homolog 2 (Spns2). J. Med. Chem. 2023, 66, 5873–5891. [DOI]

  3. Kharel, Y.; Huang, T.; Santos, W.L.; Lynch, K.R. Assays for the Sphingosine 1-phosphate Transporter Spinster Homolog 2 (Spns2). SLAS Disc. 2023, in press.   [DOI]

  4. Tanaka, S.; Zheng, S.; Kharel, Y.; Fritzemeier, R.G.; Huang, T.; Foster, D.; Poudel, N.; Goggins, E.; Yamaoka, Y.; Rudnicka, K.P.; Lipsey, J.E.; Radel, H.V.; Ryuh, S.M.; Inoue, T.; Yao, J.; Rosin, D.L.; Schwab, S.R.; Santos, W.L.; Lynch, K.R.; Okusa, M.D. S1P signaling in perivascular cells enhances inflammation and fibrosis in the kidney. Science Trans. Med. 2022, 14, eabj2681. [DOI]

  5. Fritzemeier, R.; Foster, D.; Peralta, A.; Payette, M.; Kharel, Y.; Huang, T.; Lynch, K.R.; Santos, W.L. Discovery of in vivo active sphingosine-1-phosphate transporter (Spns2) inhibitors. J. Med. Chem. 2022, 65, 7656-7681. [DOI]